<?xml version="1.0" encoding="UTF-8"?><!--Transformation version 1.3--><legislativeDoc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="http://www.lexisnexis.com/xmlschemas/content/public/legislativedoc/1/" schemaVersion="1.0"><legislativeDocHead><citations><citeForThisResource citeDefinition="#7159#349#000059#     1#          533#">Va. Code Ann. § 59.1-533</citeForThisResource></citations><legislativeBodyInfo><jurisdiction><jurisSystem normalizedLongName="Virginia" normalizedShortName="VA"/></jurisdiction></legislativeBodyInfo></legislativeDocHead><legislativeDocBody><statute><level levelType="section"><anchor id="_59.1-533"/><heading><desig>§ 59.1-533.</desig><title>Definitions</title></heading><bodyText><p>As used in this chapter:</p><p><emphasis typeStyle="it">"Influenza vaccine"</emphasis> means a vaccine, intended to be administered by injection, that contains inactivated influenza viruses, that is prepared for the applicable influenza season.</p><p><emphasis typeStyle="it">"Influenza vaccine shortage period"</emphasis> means the period of time during which a proclamation of the Governor provides that an influenza vaccine shortage exists.</p></bodyText><history><historyGroup groupType="history-citation"><historyItem><bodyText><p><citation normalizedCite="2005 VA CH 861"><content><span normalizedCite="2005 Va. Ch. 861">2005, c. 861<locator><locatorKey><keyName name="citeReference"/><keyValue value="#1834#131#2005#000861#"/></locatorKey></locator></span></content></citation>.</p></bodyText></historyItem></historyGroup></history></level></statute></legislativeDocBody><metadata><dc:metadata xmlns:dc="http://purl.org/dc/elements/1.1/"><dc:identifier identifierScheme="PGUID">urn:contentItem:5K0Y-PVF0-004G-K4M0-00000-00</dc:identifier><dc:source sourceScheme="productContentSetIdentifier">10816</dc:source><dc:date dateType="last-updated">2016-06-15</dc:date></dc:metadata><publicationInfo><publicationName>CODE OF VIRGINIA </publicationName><copyright>Copyright © 2016  by Matthew Bender &amp; Company, Inc. a member of the LexisNexis Group. All rights reserved</copyright></publicationInfo><hierarchy><hierarchyLevel levelType="title"><heading><desig>TITLE 59.1.</desig><title>TRADE AND COMMERCE</title></heading><hierarchyLevel levelType="chapter"><heading><desig>CHAPTER 48.</desig><title>INFLUENZA VACCINE PRICE GOUGING</title></heading></hierarchyLevel></hierarchyLevel></hierarchy><classificationGroup classificationScheme="indexing-terms"><classification classificationScheme="legal"><classificationItem><className>Business &amp; Corporate Compliance</className><classCode>Z3VpZD11cm46dG9waWM6MUFEMUQ2QTA1OUZCNEE5RjkzNTA2RERFMUNEOTk1RTI7cGFyZW50Z3VpZD0</classCode><classificationItem score="90"><className>Antitrust</className><classCode>Z3VpZD11cm46dG9waWM6REEyRTNDM0JGQzYyNEMyOEFGNTAwNUJEOUU1MDg4NjU7cGFyZW50Z3VpZD11cm46dG9waWM6MUFEMUQ2QTA1OUZCNEE5RjkzNTA2RERFMUNEOTk1RTI</classCode></classificationItem></classificationItem></classification></classificationGroup></metadata></legislativeDoc>